Form 8-K - Current report:
SEC Accession No. 0001104659-21-011590
Filing Date
2021-02-03
Accepted
2021-02-03 16:42:17
Documents
12
Period of Report
2021-02-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm213890d3_8k.htm   iXBRL 8-K 75550
  Complete submission text file 0001104659-21-011590.txt   261175

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rytm-20210202.xsd EX-101.SCH 3187
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rytm-20210202_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rytm-20210202_pre.xml EX-101.PRE 22711
5 EXTRACTED XBRL INSTANCE DOCUMENT tm213890d3_8k_htm.xml XML 3618
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38223 | Film No.: 21586746
SIC: 2834 Pharmaceutical Preparations